Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: NCI clinical trials planning meeting report on identifying key genes and molecular pathways for targeted endometrial cancer trials
ONCOTARGET (2017)
期刊
ONCOTARGET
卷 8, 期 48, 页码 84579-84594出版社
IMPACT JOURNALS LLC
关键词
作者
我是这篇论文的作者
推荐
Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities
Pouya Javadian, Chao Xu, Virginie Sjoelund, Lindsay E. Borden, Justin Garland, Doris Mangiaracina Benbrook
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
In search for biomarkers and potential drug targets for uterine serous endometrial cancer
Giorgia Dinoi, Andrea Mariani, Enrica Martinelli, Alessandra Ciucci, Gian Franco Zannoni, Amy L. Weaver, Gary L. Keeney, George Vasmatzis, Panos Z. Anastasiadis, Francesco Fanfani, Giovanni Scambia, Daniela Gallo
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival
Nora Dieguez-Martinez, Sergio Espinosa-Gil, Guillermo Yoldi, Elisabet Megias-Roda, Idoia Bolinaga-Ayala, Maria Vinas-Casas, Gokhan Gorgisen, Ines Domingo-Orti, Hector Perez-Montoyo, Jose R. Bayascas, Eva Colas, Xavier Dolcet, Jose M. Lizcano
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation?
Miriam Dellino, Marco Cerbone, Antonio Simone Lagana, Amerigo Vitagliano, Antonella Vimercati, Marco Marinaccio, Giorgio Maria Baldini, Antonio Malvasi, Ettore Cicinelli, Gianluca Raffaello Damiani, Gerardo Cazzato, Eliano Cascardi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Molecular Monitoring in Endometrial Cancer-Ready for Prime Time?
Brooke M. Grant, Trevor J. Pugh, Amit M. Oza
CLINICAL CANCER RESEARCH (2023)
TERT promoter mutations and gene amplification in endometrial cancer
Aaron M. Praiss, Antonio Marra, Qin Zhou, Eric Rios-Doria, Amir Momeni-Boroujeni, Alexia Iasonos, Pier Selenica, David N. Brown, Carol Aghajanian, Nadeem R. Abu-Rustum, Lora H. Ellenson, Britta Weigelt
GYNECOLOGIC ONCOLOGY (2023)
Rare Subtype of Endometrial Cancer: Undifferentiated/Dedifferentiated Endometrial Carcinoma, from Genetic Aspects to Clinical Practice
Hsiu-Jung Tung, Ren-Chin Wu, Chiao-Yun Lin, Chyong-Huey Lai
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
New Insights into Endometrial Cancer
Laura Paleari, Silvia Pesce, Mariangela Rutigliani, Marco Greppi, Valentina Obino, Franco Gorlero, Valerio Gaetano Vellone, Emanuela Marcenaro
CANCERS (2021)
Endometrial cancer
Emma J. Crosbie, Sarah J. Kitson, Jessica N. McAlpine, Asima Mukhopadhyay, Melanie E. Powell, Naveena Singh
LANCET (2022)
Molecular profiles of endometrial cancer tumors among Black patients
Annelise M. Wilhite, Yasmine Baca, Joanne Xiu, Rajesh Paladugu, Adam C. ElNaggar, Jubilee Brown, Ira S. Winer, Robert Morris, Britt K. Erickson, Alexander B. Olawaiye, Matthew Powell, W. Michael Korn, Rodney P. Rocconi, Dineo Khabele, Nathaniel L. Jones
GYNECOLOGIC ONCOLOGY (2022)
Curcumin anti-tumor effects on endometrial cancer with focus on its molecular targets
Fahime Jahanbakhshi, Parisa Maleki Dana, Bita Badehnoosh, Bahman Yousefi, Mohammad Ali Mansournia, Moghadeseh Jahanshahi, Zatollah Asemi, Jamal Halajzadeh
CANCER CELL INTERNATIONAL (2021)
Network Pharmacology Analysis of Huangqi Jianzhong Tang Targets in Gastric Cancer
Long Li, Yizhuo Lu, Yanling Liu, Dan Wang, Linshan Duan, Shuyu Cheng, Guoyan Liu
FRONTIERS IN PHARMACOLOGY (2022)
Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer
Setsuko K. Chambers
CANCERS (2022)
Investigating into anti-cancer potential of lycopene: Molecular targets
Wang Jia Qi, Wang Shi Sheng, Chu Peng, Ma Xiaodong, Tang Ze Yao
BIOMEDICINE & PHARMACOTHERAPY (2021)
Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer
Meiling Fan, Mengyao Shan, Xintian Lan, Xiaoxue Fang, Dimeng Song, Haoming Luo, Donglu Wu
FRONTIERS IN PHARMACOLOGY (2022)
Introduction: the 12th Biennial Rivkin Center Ovarian Cancer Research Symposium
Nita J. Maihle, Douglas A. Levine, Kiran Dhillon, Deborah Kay Armstrong
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Proteogenomic Characterization of Endometrial Carcinoma
Yongchao Dou, Emily A. Kawaler, Daniel Cui Zhou, Marina A. Gritsenko, Chen Huang, Lili Blumenberg, Alla Karpova, Vladislav A. Petyuk, Sara R. Savage, Shankha Satpathy, Wenke Liu, Yige Wu, Chia-Feng Tsai, Bo Wen, Zhi Li, Song Cao, Jamie Moon, Zhiao Shi, MacIntosh Cornwell, Matthew A. Wyczalkowski, Rosalie K. Chu, Suhas Vasaikar, Hua Zhou, Qingsong Gao, Ronald J. Moore, Kai Li, Sunantha Sethuraman, Matthew E. Monroe, Rui Zhao, David Heiman, Karsten Krug, Karl Clauser, Ramani Kothadia, Yosef Maruvka, Alexander R. Pico, Amanda E. Oliphant, Emily L. Hoskins, Samuel L. Pugh, Sean J. I. Beecroft, David W. Adams, Jonathan C. Jarman, Andy Kong, Hui-Yin Chang, Boris Reva, Yuxing Liao, Dmitry Rykunov, Antonio Colaprico, Xi Steven Chen, Andrzej Czekanski, Marcin Jedryka, Rafa Matkowski, Maciej Wiznerowicz, Tara Hiltke, Emily Boja, Christopher R. Kinsinger, Mehdi Mesri, Ana I. Robles, Henry Rodriguez, David Mutch, Katherine Fuh, Matthew J. Ellis, Deborah DeLair, Mathangi Thiagarajan, D. R. Mani, Gad Getz, Michael Noble, Alexey I. Nesvizhskii, Pei Wang, Matthew L. Anderson, Douglas A. Levine, Richard D. Smith, Samuel H. Payne, Kelly V. Ruggles, Karin D. Rodland, Li Ding, Bing Zhang, Tao Liu, David Fenyo
CELL (2020)
Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression
Melissa K. Frey, Sarah S. Lee, Deanna Gerber, Zachary P. Schwartz, Jessica Martineau, Kathleen Lutz, Erin Reese, Emily Dalton, Annie Olsen, Julia Girdler, Bhavana Pothuri, Leslie Boyd, John P. Curtin, Douglas A. Levine, Stephanie Blank
GYNECOLOGIC ONCOLOGY (2020)
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Panagiotis A. Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N. Grisham, Paul J. Goodfellow, Elise C. Kohn, Douglas A. Levine, Joyce F. Liu, Karen H. Lu, Dorinda Sparacio, Christina M. Annunziata
JOURNAL OF CLINICAL ONCOLOGY (2020)
Prognostic gene expression signature for high-grade serous ovarian cancer
J. Millstein, T. Budden, E. L. Goode, M. S. Anglesio, A. Talhouk, M. P. Intermaggio, H. S. Leong, S. Chen, W. Elatre, B. Gilks, T. Nazeran, M. Volchek, R. C. Bentley, C. Wang, D. S. Chiu, S. Kommoss, S. C. Y. Leung, J. Senz, A. Lum, V Chow, H. Sudderuddin, R. Mackenzie, J. George, S. Fereday, J. Hendley, N. Traficante, H. Steed, J. M. Koziak, M. Kobel, I. A. McNeish, T. Goranova, D. Ennis, G. Macintyre, D. Silva De Silva, T. Ramon y Cajal, J. Garcia-Donas, S. Hernando Polo, G. C. Rodriguez, K. L. Cushing-Haugen, H. R. Harris, C. S. Greene, R. A. Zelaya, S. Behrens, R. T. Fortner, P. Sinn, E. Herpel, J. Lester, J. Lubinski, O. Oszurek, A. Toloczko, C. Cybulski, J. Menkiszak, C. L. Pearce, M. C. Pike, C. Tseng, J. Alsop, V Rhenius, H. Song, M. Jimenez-Linan, A. M. Piskorz, A. Gentry-Maharaj, C. Karpinskyj, M. Widschwendter, N. Singh, C. J. Kennedy, R. Sharma, P. R. Harnett, B. Gao, S. E. Johnatty, R. Sayer, J. Boros, S. J. Winham, G. L. Keeney, S. H. Kaufmann, M. C. Larson, H. Luk, B. Y. Hernandez, P. J. Thompson, L. R. Wilkens, M. E. Carney, B. Trabert, J. Lissowska, L. Brinton, M. E. Sherman, C. Bodelon, S. Hinsley, L. A. Lewsley, R. Glasspool, S. N. Banerjee, E. A. Stronach, P. Haluska, I Ray-Coquard, S. Mahner, B. Winterhoff, D. Slamon, D. A. Levine, L. E. Kelemen, J. Benitez, J. Chang-Claude, J. Gronwald, A. H. Wu, U. Menon, M. T. Goodman, J. M. Schildkraut, N. Wentzensen, R. Brown, A. Berchuck, G. Chenevix-Trench, A. DeFazio, S. A. Gayther, M. J. Garcia, M. J. Henderson, M. A. Rossing, A. Beeghly-Fadiel, P. A. Fasching, S. Orsulic, B. Y. Karlan, G. E. Konecny, D. G. Huntsman, D. D. Bowtell, J. D. Brenton, J. A. Doherty, P. D. P. Pharoah, S. J. Ramus
ANNALS OF ONCOLOGY (2020)
Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines
Marc Tischkowitz, Sidong Huang, Susana Banerjee, Jennifer Hague, William P. D. Hendricks, David G. Huntsman, Jessica D. Lang, Krystal A. Orlando, Amit M. Oza, Patricia Pautier, Isabelle Ray-Coquard, Jeffrey M. Trent, Michael Witcher, Leora Witkowski, W. Glenn McCluggage, Douglas A. Levine, William D. Foulkes, Bernard E. Weissman
CLINICAL CANCER RESEARCH (2020)
Not all driver mutations are equal
Victoria L. Bae-Jump, Douglas A. Levine
NATURE (2020)
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
Honglin Song, Ed M. Dicks, Jonathan Tyrer, Maria Intermaggio, Georgia Chenevix-Trench, David D. Bowtell, Nadia Traficante, James Brenton, Teodora Goranova, Karen Hosking, Anna Piskorz, Elke van Oudenhove, Jen Doherty, Holly R. Harris, Mary Anne Rossing, Matthias Duerst, Thilo Dork, Natalia Bogdanova, Francesmary Modugno, Kirsten Moysich, Kunle Odunsi, Roberta Ness, Beth Y. Karlan, Jenny Lester, Allan Jensen, Susanne Kruger Kjaer, Estrid Hogdall, Ian G. Campbell, Conxi Lazaro, Miguel Angel Pujara, Julie Cunningham, Robert Vierkant, Stacey J. Winham, Michelle Hildebrandt, Chad Huff, Donghui Li, Xifeng Wu, Yao Yu, Jennifer B. Permuth, Douglas A. Levine, Joellen M. Schildkraut, Marjorie J. Riggan, Andrew Berchuck, Penelope M. Webb, Cezary Cybulski, Jacek Gronwald, Anna Jakubowska, Jan Lubinski, Jennifer Alsop, Patricia Harrington, Isaac Chan, Usha Menon, Celeste L. Pearce, Anna H. Wu, Anna de Fazio, Catherine J. Kennedy, Ellen Goode, Susan Ramus, Simon Gayther, Paul Pharoah
JOURNAL OF MEDICAL GENETICS (2021)
State of the science: Uterine sarcomas: From pathology to practice
Alexander Shushkevich, Premal H. Thaker, Ramey D. Littell, Naishadh A. Shah, Sarah Chiang, Katherine Thornton, Martee L. Hensley, Brian M. Slomovitz, Kevin M. Holcomb, Mario M. Leitao, Michael D. Toboni, Matthew A. Powell, Douglas A. Levine, Sean C. Dowdy, Ann Klopp, Jubilee Brown
GYNECOLOGIC ONCOLOGY (2020)
Angiogenesis in endometrial carcinoma: Therapies and biomarkers, current options, and future perspectives
Amnon A. Berger, Fanny Dao, Douglas A. Levine
GYNECOLOGIC ONCOLOGY (2021)
Integrated Multi-Tumor Radio-Genomic Marker of Outcomes in Patients with High Serous Ovarian Carcinoma
Harini Veeraraghavan, Herbert Alberto Vargas, Sanchez Alejandro-Jimenez, Maura Micco, Eralda Mema, Yulia Lakhman, Mireia Crispin-Ortuzar, Erich P. Huang, Douglas A. Levine, Rachel N. Grisham, Nadeem Abu-Rustum, Joseph O. Deasy, Alexandra Snyder, Martin L. Miller, James D. Brenton, Evis Sala
CANCERS (2020)
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study
Kimberly K. Leslie, Virginia L. Filiaci, Adrianne R. Mallen, Kristina W. Thiel, Eric J. Devor, Katherine Moxley, Debra Richardson, David Mutch, Angeles Alvarez Secord, Krishnansu S. Tewari, Megan E. McDonald, Cara Mathews, Casey Cosgrove, Summer Dewdney, Yovanni Casablanca, Amanda Jackson, Peter G. Rose, XunClare Zhou, Michael McHale, Heather Lankes, Douglas A. Levine, Carol Aghajanian
GYNECOLOGIC ONCOLOGY (2021)
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis
Jessica N. McAlpine, Derek S. Chiu, Remi A. Nout, David N. Church, Pascal Schmidt, Stephanie Lam, Samuel Leung, Stefania Bellone, Adele Wong, Sara Y. Brucker, Cheng Han Lee, Blaise A. Clarke, David G. Huntsman, Marcus Q. Bernardini, Joanne Ngeow, Alessandro D. Santin, Paul Goodfellow, Douglas A. Levine, Martin Kobel, Stefan Kommoss, Tjalling Bosse, C. Blake Gilks, Aline Talhouk
CANCER (2021)
Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis
Jessica N. McAlpine, Derek S. Chiu, Remi A. Nout, David N. Church, Pascal Schmidt, Stephanie Lam, Samuel Leung, Stefania Bellone, Adele Wong, Sara Y. Brucker, Cheng Han Lee, Blaise A. Clarke, David G. Huntsman, Marcus Q. Bernardini, Joanne Ngeow, Alessandro D. Santin, Paul Goodfellow, Douglas A. Levine, Martin Kobel, Stefan Kommoss, Tjalling Bosse, C. Blake Gilks, Aline Talhouk
CANCER (2021)
Genetically Defined, Syngeneic Organoid Platform for Developing Combination Therapies for Ovarian Cancer
Shuang Zhang, Sonia Iyer, Hao Ran, Igor Dolgalev, Shengqing Gu, Wei Wei, Connor J. R. Foster, Cynthia A. Loomis, Narciso Olvera, Fanny Dao, Douglas A. Levine, Robert A. Weinberg, Benjamin G. Neel
CANCER DISCOVERY (2021)